Foley is pleased to be a Gold sponsor of the Sino-American Biomedical and Pharmaceutical Association (SABPA) 5th Annual Pacific Forum. The conference brings together entrepreneurs, scientists, investors, executives, and policy makers to promote life sciences and biotechnology alliances across the Pacific Rim, including the U.S. West coast, greater China region, and Singapore.
Foley Partner Stephen Bent will participate on a panel discussion on November 7th at 2:30 p.m. on “What is Your China Play – Doing Business in a Shifting Regulatory, Investment, and Economic Environment.”
For more information about the SABPA 5th Annual Pacific Forum, please visit the SABPA Web site.
People
Related Insights
21 March 2025
IP Litigation Current
Federal Circuit Opens the Door to Additional Domestic Industry Investment: “Ordinary Importer” No Longer
In its recent decision in Lashify, Inc. v. International Trade Commission, the Federal Circuit opened the door for patent owners to include expanded categories of domestic investment to satisfy the economic prong of the domestic industry requirement under Section 337(a)(3)(B).
21 March 2025
Manufacturing Industry Advisor
Federal Court Rejects FCA’s “65%-100%” Language as Insufficient to Constitute the Necessary Quantity Term in a Requirements Contract—A Win for Suppliers
A recent federal court decision marks an important win for automotive suppliers in the ongoing debate over what constitutes a valid requirements contract under Michigan law following the Michigan Supreme Court’s decision in MSSN, Inc. v. Airboss Flexible Products Co. (2023).
27 April 2025
Events
Innovative Payment Strategies in Proton Therapy: Addressing Challenges and Driving Value
Foley partner Kinal Patel is speaking at the 2025 National Proton Conference in a panel titled “Innovative Payment Strategies in Proton Therapy: Addressing Challenges and Driving Value” on April 27.